Pharmacologic therapy of chronic heart failure.

Pharmacologic therapy of chronic heart failure.

Item
http://www.wikidata.org/entity/Q36909112
Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathyPharmacological interventions for treating heart failure in patients with Chagas cardiomyopathyMyocardial adeno-associated virus serotype 6-betaARKct gene therapy improves cardiac function and normalizes the neurohormonal axis in chronic heart failurePharmacological interventions for treating heart failure in patients with Chagas cardiomyopathyToxicarioside A inhibits tumor growth and angiogenesis: involvement of TGF-β/endoglin signalingStrophalloside induces apoptosis of SGC-7901 cells through the mitochondrion-dependent caspase-3 pathway.Toxicarioside A inhibits SGC-7901 proliferation, migration and invasion via NF-κB/bFGF signaling.Glucagon and a glucagon-GLP-1 dual-agonist increases cardiac performance with different metabolic effects in insulin-resistant hearts.The Molecular Basis of Toxins' Interactions with Intracellular Signaling via Discrete Portals.3′-epi-12β-hydroxyfroside, a new cardenolide, induces cytoprotective autophagy via blocking the Hsp90/Akt/mTOR axis in lung cancer cells.
P2860

Pharmacologic therapy of chronic heart failure.

Item
http://www.wikidata.org/entity/Q36909112
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Pharmacologic therapy of chronic heart failure.
@en
type
label
Pharmacologic therapy of chronic heart failure.
@en
prefLabel
Pharmacologic therapy of chronic heart failure.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P6179
P698
P356
P1433
P1476
Pharmacologic therapy of chronic heart failure
@en
P2093
P2860
P2888
P304
P31
P356
10.2165/00129784-200707040-00002
P433
P478
P50
P577
P6179
P698